(Total Views: 432)
Posted On: 02/10/2025 8:59:33 AM
Post# of 153218
Maybe a multi-faceted consortium of Governments, based on Dr. J's 1600 patient data comment:
"& without a discernible safety signal",
fund about 15/20 different Phase 3 trials of Leronlimab.
Given changes in the world, that would be right up Max's alley.
Oct. 8th 2024:
"...Dr. Lataillade will lead the Company’s global research and development strategy and oversee end-to-end R&D activities to advance the Company’s clinical development pipeline."
"& without a discernible safety signal",
fund about 15/20 different Phase 3 trials of Leronlimab.
Given changes in the world, that would be right up Max's alley.
Oct. 8th 2024:
"...Dr. Lataillade will lead the Company’s global research and development strategy and oversee end-to-end R&D activities to advance the Company’s clinical development pipeline."
(3)
(0)Scroll down for more posts ▼
